You have access
Administration of Nivolumab in Metastatic Renal Cell Cancer Following Treatment With mTOR Inhibitors
JINDRICH KOPECKY, ONDREJ KUBECEK, TOMAS BUCHLER, BOHUSLAV MELICHAR, ALEXANDR POPRACH, MILADA ZEMANOVA, JANA KATOLICKA, IGOR KISS, JAROSLAV HAJEK, HANA STUDENTOVA and MARTINA SPISAROVA
In Vivo September 2021, 35 (5) 2981-2990; DOI: https://doi.org/10.21873/invivo.12593